Gemcitabin Hexal 1 gm/vial (IV Infusion)
1 gm vial: ৳ 3,937.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Gemcitabine |
| Company | Sandoz a novartis division |
| Also available as |
Indications
- Treatment of non-small cell lung cancer
- Treatment of pancreatic cancer
- Treatment of bladder cancer
- Treatment of breast cancer
- Treatment of ovarian cancer
Pharmacology
- Metabolism by nucleoside kinases
- Inhibition of DNA synthesis
- Induction of apoptosis
Dosage & Administration
- Recommended dosages for different types of cancer
- Intravenous infusion instructions
- Dosage reduction guidelines
Interaction
- No confirmed interactions reported
- No specific drug interaction studies conducted
Contraindications
- Contraindicated in patients with known hypersensitivity to the product
Side Effects
- Haematological toxicity
- Hepatic toxicity
- Gastrointestinal issues
- Genito-urinary toxicity
- Pulmonary toxicity
- Allergic reactions
- Neurotoxicity
- Alopecia
Pregnancy & Lactation
- Pregnancy Category D
- Use during pregnancy
- Unknown excretion in human breast milk
Precautions & Warnings
- Caution in patients with specific risks and conditions
Use in Special Populations
- Elderly patients
- Renal and hepatic impairment
- Limited data on use in children
Overdose Effects
- No known antidote
- Principal toxicities seen in overdose cases
Therapeutic Class
- Cytotoxic Chemotherapy
Storage Conditions
- Store in original carton at 20-25°C
- Avoid refrigeration to prevent crystallisation
- Keep out of the reach of children
Related Brands
- Gemzar 200 mg/vial (IV Infusion) - eli-lilly-and-company
- Gemoxen 200 mg/vial (IV Infusion) - beacon-pharmaceuticals-plc
- Gitabin 200 mg/vial (IV Infusion) - bots-pvt-limited
- Gemcitabine PhaRes 200 mg/vial (IV Infusion) - thymoorgan-pharmazie-gmbh-germany
- Gemcetin 200 mg/vial (IV Infusion) - techno-drugs-ltd